Rola chemioterapii neoadiuwantowej w leczeniu skojarzonym raka piersi

Abstract

Author(s): JACEK TOMCZYKOWSKI, KRZYSZTOF PATYRA

Neoadjuvant chemotherapy is a recognized means of combined treatment of locally advanced breast cancer, and in less advanced cases it can be used in the hope of allowing greater conservation of the breast. Modern neoadjuvant chemiotherapy programmes can lead to 31-65% of pathological complete response. A direct comparison of neoadjuvant chemotherapy with an identical adjuvant treatment has not pointed to a significant increase in overal survivall. It is hoped that neoadjuvant chemotherapy will be more widely used in treatment of breast cancer. A thorough assessment of tumor response to primary chemotherapy offers a practical possibility to optimise treatment, and maybe changes of concept in treatment in this kind of cancer.

<

Share this article

Awards Nomination
qr

Editors List

  • Ahmed Hussien Alshewered

    University of Basrah College of Medicine, Iraq

  • Sudhakar Tummala

    Department of Electronics and Communication Engineering SRM University – AP, Andhra Pradesh

     

     

     

  • Alphonse Laya

    Supervisor of Biochemistry Lab and PhD. students of Faculty of Science, Department of Chemistry and Department of Chemis

     

  • Fava Maria Giovanna

     

  • Manuprasad Avaronnan

Google Scholar citation report
Citations : 558

Onkologia i Radioterapia received 558 citations as per Google Scholar report

Flyer image
Onkologia i Radioterapia peer review process verified at publons
Flyer image
Indexed In
  • Directory of Open Access Journals
  • Scimago
  • SCOPUS
  • EBSCO A-Z
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20
View More